Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17100110 | 0.82 | CA1 (0.32) | CA1CA9 | |
| SCHEMBL28549225 | 0.80 | ALDH1A1 (0.31) | CA1CA9ALDH1A1 | |
| SCHEMBL16039711 | 0.76 | KDM4E (0.33) | CA1CA9ALDH1A1KMT2A | |
| Bicarbonate SCHEMBL16553371 | 0.75 | CA1 (0.33) | CA1CA9ALDH1A1KMT2A | |
| SCHEMBL4895573 | 0.73 | ALDH1A1 (0.35) | ALDH1A1 | |
| SCHEMBL35964 | 0.71 | CA1 (0.37) | CA1CA9 | |
| SCHEMBL7112607 | 0.70 | CA1 (0.40) | CA1CA9ALDH1A1 | |
| SCHEMBL715504 | 0.70 | CA1 (0.36) | CA1CA9 | |
| SCHEMBL9247017 | 0.69 | CA1 (0.39) | CA1CA9ALDH1A1 | |
| SCHEMBL430902 | 0.69 | CA1 (0.39) | CA1CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109790285-B | Hybrid material and method for producing the same | 帝国理工学院创新有限公司 | 2022-06-21 | — | — | CN | claimed |
| EP-2486081-B1 | BIOCOMPATIBLE POLYMERS FOR MEDIAL DEVICES | UNIV RUTGERS (US) | 2018-12-05 | — | — | EP | claimed |
| US-20120226013-A1 | BIOCOMPATIBLE POLYMERS FOR MEDIAL DEVICES | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2012-09-06 | — | — | US | claimed |
| EP-2486081-A1 | BIOCOMPATIBLE POLYMERS FOR MEDIAL DEVICES | Rutgers, The State University of New Jersey (US) | 2012-08-15 | — | — | EP | claimed |
| WO-2011044567-A1 | BIOCOMPATIBLE POLYMERS FOR MEDIAL DEVICES | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2011-04-14 | — | — | WO | claimed |
| CN-109790285-B | Hybrid material and method for producing the same | 帝国理工学院创新有限公司 | 2022-06-21 | — | — | CN | disclosed |
| US-11118011-B2 | Biocompatible polymers for medical devices | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2021-09-14 | — | — | US | disclosed |
| CN-107108863-B | Biocompatible diphenoliodide monomers and polymers | 新泽西鲁特格斯州立大学 | 2021-03-19 | — | — | CN | disclosed |
| EP-3237487-B1 | BIOCOMPATIBLE IODINATED DIPHENOL MONOMERS AND POLYMERS | UNIV RUTGERS (US) | 2021-02-17 | — | — | EP | disclosed |
| US-10787542-B2 | Hybrid materials and process for production thereof | IMPERIAL COLLEGE INNOVATIONS LIMITED (GB) | 2020-09-29 | — | — | US | disclosed |
| EP-3461855-B1 | BIOCOMPATIBLE POLYMERS FOR MEDICAL DEVICES | UNIV RUTGERS (US) | 2020-05-27 | — | — | EP | disclosed |
| US-20190185624-A1 | BIOCOMPATIBLE POLYMERS FOR MEDICAL DEVICES | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY | 2019-06-20 | — | — | US | disclosed |
| US-7749539-B2 | Therapy for tumor or bone infections; antitumor agents; anticancer agents; bactericides; antiinflammatory agents; administering by injection | EFRAT BIOPOLYMERS LTD. (IL) | 2010-07-06 | — | — | US | disclosed |
| WO-2010042918-A1 | BIOCOMPATIBLE POLYMERS FOR MEDICAL DEVICES | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2010-04-15 | — | — | WO | disclosed |
| WO-2010026590-A2 | NOVEL BIODEGRADABLE ADHESIVE COMPOSITIONS | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM, LTD (IL) | 2010-03-11 | — | — | WO | disclosed |
| US-7297347-B2 | Polyanhydrides | EFRAT BIOPOLYMERS LTD (IL) | 2007-11-20 | — | — | US | disclosed |
| US-20040161464-A1 | Polymeric formulations for drug delivery | EFRAT BIOPOLYMERS LTD. | 2004-08-19 | — | — | US | disclosed |
| US-20040057970-A1 | Polyanhydrides | EFRAT BIOPOLYMERS LTD. (IL) | 2004-03-25 | — | — | US | disclosed |
| EP-1339776-A2 | POLYANHYDRIDES | Efrat Biopolymers Ltd. (IL) | 2003-09-03 | — | — | EP | disclosed |
| WO-2002044232-A2 | POLYANHYDRIDES | EFRAT BIOPOLYMERS LTD. (IL) | 2002-06-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040057970-A1 | Polyanhydrides | PARG, PARN, AHR | CA1 2647/4885CA9 1307/4885ALDH1A1 2061/4885 |
| US-20040161464-A1 | Polymeric formulations for drug delivery | SBDS, AR, CD47 | CA1 20/4885CA9 13/4885ALDH1A1 2451/4885 |
| US-20120226013-A1 | BIOCOMPATIBLE POLYMERS FOR MEDIAL DEVICES | MATR3, MIF, BMP2 | CA1 4391/4885CA9 2985/4885ALDH1A1 4752/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.